234 related articles for article (PubMed ID: 34919143)
1. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer.
Masetti M; Carriero R; Portale F; Marelli G; Morina N; Pandini M; Iovino M; Partini B; Erreni M; Ponzetta A; Magrini E; Colombo P; Elefante G; Colombo FS; den Haan JMM; Peano C; Cibella J; Termanini A; Kunderfranco P; Brummelman J; Chung MWH; Lazzeri M; Hurle R; Casale P; Lugli E; DePinho RA; Mukhopadhyay S; Gordon S; Di Mitri D
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34919143
[TBL] [Abstract][Full Text] [Related]
2. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
3. CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling.
Huang R; Wang S; Wang N; Zheng Y; Zhou J; Yang B; Wang X; Zhang J; Guo L; Wang S; Chen Z; Wang Z; Xiang S
Cell Death Dis; 2020 Apr; 11(4):234. PubMed ID: 32300100
[TBL] [Abstract][Full Text] [Related]
4. Identification and Functional Analysis of EPOR
Li Y; Li M; Wei R; Wu J
J Immunol Res; 2020; 2020():9374240. PubMed ID: 32908942
[TBL] [Abstract][Full Text] [Related]
5. Spatial distribution of tumor-associated macrophages in an orthotopic prostate cancer mouse model.
Grayson KA; Greenlee JD; Himmel LE; Hapach LA; Reinhart-King CA; King MR
Pathol Oncol Res; 2024; 30():1611586. PubMed ID: 38689823
[TBL] [Abstract][Full Text] [Related]
6. A tumor-associated macrophages related model for predicting biochemical recurrence and tumor immune environment in prostate cancer.
Chen JY; Huang XY; Lin F; You Q; Xue YT; Lin B; Zheng QS; Wei Y; Xue XY; Li XD; Chen DN; Xu N
Genomics; 2023 Sep; 115(5):110691. PubMed ID: 37516327
[TBL] [Abstract][Full Text] [Related]
7. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer.
Luo Q; Zheng N; Jiang L; Wang T; Zhang P; Liu Y; Zheng P; Wang W; Xie G; Chen L; Li D; Dong P; Yuan X; Shen L
Cancer Sci; 2020 Nov; 111(11):4000-4011. PubMed ID: 32798273
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer.
Guan H; Peng R; Fang F; Mao L; Chen Z; Yang S; Dai C; Wu H; Wang C; Feng N; Xu B; Chen M
J Cell Physiol; 2020 Dec; 235(12):9729-9742. PubMed ID: 32406953
[TBL] [Abstract][Full Text] [Related]
9. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment.
Chen PC; Cheng HC; Wang J; Wang SW; Tai HC; Lin CW; Tang CH
Oncotarget; 2014 Mar; 5(6):1595-608. PubMed ID: 24721786
[TBL] [Abstract][Full Text] [Related]
11. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
13. Mouse 4T1 Breast Cancer Cell-Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183.
Guo J; Duan Z; Zhang C; Wang W; He H; Liu Y; Wu P; Wang S; Song M; Chen H; Chen C; Si Q; Xiang R; Luo Y
J Immunol; 2020 Nov; 205(10):2916-2925. PubMed ID: 32989094
[TBL] [Abstract][Full Text] [Related]
14. Lipid Metabolic Regulatory Crosstalk Between Cancer Cells and Tumor-Associated Macrophages.
Liu S; Shen YY; Yin LY; Liu J; Zu X
DNA Cell Biol; 2023 Aug; 42(8):445-455. PubMed ID: 37535386
[TBL] [Abstract][Full Text] [Related]
15. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
Li L; Ma SR; Yu ZL
Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
[TBL] [Abstract][Full Text] [Related]
16. Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.
Zeng J; Yang X; Yang L; Li W; Zheng Y
Respir Res; 2020 Dec; 21(1):328. PubMed ID: 33349268
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
[TBL] [Abstract][Full Text] [Related]
18. Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells.
Miao L; Qi J; Zhao Q; Wu QN; Wei DL; Wei XL; Liu J; Chen J; Zeng ZL; Ju HQ; Luo HY; Xu RH
Theranostics; 2020; 10(2):498-515. PubMed ID: 31903134
[No Abstract] [Full Text] [Related]
19. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
20. Lipid-loaded macrophages as new therapeutic target in cancer.
Marelli G; Morina N; Portale F; Pandini M; Iovino M; Di Conza G; Ho PC; Di Mitri D
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35798535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
